Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology-Reference-Cited by-同舟云学术

Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology

Published:2020-02 Issue: Volume:134 Page:104636
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Joly-Amado A.,Davtyan H.,Serraneau K.,Jules P.,Zitnyar A.,Pressman E.,Zagorski K.,Antonyan T.,Hovakimyan A.,Paek H.J.,Gordon M.N.,Cribbs D.H.,Petrovsky N.,Agadjanyan M.G.,Ghochikyan A.,Morgan D.

Funder

NIH

NIAID/NIH

Publisher

Elsevier BV

Subject

Neurology

Reference66 articles.

1. A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer’s disease;Agadjanyan;Alzheimers Dement.,2015

2. Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency;Agadjanyan;Mol. Neurodegener.,2017

3. Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice;Alamed;Nat. Protoc.,2006

4. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody;Albert;Brain,2019

5. Time-dependent variations in aversively motivated behaviors: nonassociative effects of cholinergic and catecholaminergic activity;Anisman;Psychol. Rev.,1975

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein modification in neurodegenerative diseases;MedComm;2024-08

2. Black phosphorus nanosheets as therapeutic “garbage trucks” for the selective clearance of peripheral phosphorylated Tau proteins in Alzheimer’s disease;Chemical Engineering Journal;2024-04

3. Atomic insights into the inhibition of R3 domain of tau protein by epigallocatechin gallate, quercetin and gallic acid;Biophysical Chemistry;2024-02

4. The evolution of Alzheimer’s disease therapies: A comprehensive review;Annals of Medical Science & Research;2024-01

5. Administration of recombinant FOXN1 protein attenuates Alzheimer’s pathology in mice;Brain, Behavior, and Immunity;2023-10